Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Interleukin-2 × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 9 Dermatologic 4 Thoracic 3 Gynecologic 3 Gastrointestinal 3 Breast 2 Sarcoma 1 NET 1 Lymphoid 1 Genitourinary 1 Endocrine 1

Conditions

Sarcoma 1 Neuroendocrine Tumors 1 Head and Neck Neoplasms 1

Interventions

repotrectinib 1 pralsetinib 1 entrectinib 1 alectinib 1 Quality of Life 1 Patient Reported Outcome Measures 1 Molecular Diagnostic Techniques 1 Interleukin-2 1 Immunotherapy 1 Drug Therapy 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04166006 2024-09-19

RaC-Ad

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting

EndocrineHead & NeckNETSarcoma

Head and Neck Neoplasms, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡